Published on : Jul 13, 2016
ALBANY, New York, July 13, 2016: A new market research report, titled “Global Blood Plasma Market Report: 2016 Edition,” has recently been added by ResearchMoz.us to its vast database of research reports. The 57-page research study provides a detailed analysis of the global blood plasma market and helps in determining the on-going trends and potential opportunities in the market. The research study has included insightful inputs to help blood plasma manufacturers, distributors, and suppliers in formulating market-centric policies. In addition, the research study has presented the historical data and projected statistics with the help of tables, charts, and infographics.
The increasing demand for polyvalent immunoglobulin is one of the key factors projected to encourage the growth of the global blood plasma market throughout the forecast period. Moreover, the growing healthcare expenditure is anticipated to boost the demand for blood plasma in the near future. The influx of extended half-life products for the treatment of hemophilia and new opportunities for treating alpha-1 antitrypsin deficiency (AATD) are considered as some of the key trends expected to drive the market in the coming years.
On the flip side, the rising threats of substitutes and the diminishing share of plasma-derived Factor VIII segment are some of the prominent factors inhibiting the growth of the global blood plasma market. In addition, the rising cost of production is discouraging the entry of new players in the global market, dampening the growth of the market.
Click here to get more info with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=742695
The global blood plasma market has been classified on the basis of components into albumin, immunoglobulin, alpha-1 antitrypsin (AAT) or Alpha-1 proteinase inhibitor (A1PI), and factor VIII. These components are the main antibodies and proteins, which are extracted from the blood plasma and further used for treatments of various conditions, illness, and life-threatening diseases. These medications are used in several countries across the globe as a standard course of treatment to improve the health of the patients.
Furthermore, the research study has categorized the global blood plasma market on the basis of geography in order to determine the leading regions in the market. As per the study, Asia Pacific is expected to witness substantial growth in the next few years, owing to the rising share of albumin in the recent years. On the other hand, the high industry regulations in several emerging nations, including China are projected to curb the growth of the market throughout the forecast period.
The global market for blood plasma is extremely competitive in nature, due to the presence of several players in the market. The company profiles of the leading players have been discussed in the research study, focusing on the product portfolio, business strategies, financial status, and recent developments if any. The leading players listed in the research study include CSL Limited, Baxter International Inc., Octapharma AG, and Grifols. A SWOT analysis of these players has also been presented in the study to provide a clear understanding of the global blood plasma market.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on [email protected]